{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T13:34:30Z","timestamp":1781530470401,"version":"3.54.1"},"reference-count":45,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1097\/mot.0000000000000043","type":"journal-article","created":{"date-parts":[[2013,12,25]],"date-time":"2013-12-25T11:46:25Z","timestamp":1387971985000},"page":"65-72","source":"Crossref","is-referenced-by-count":66,"title":["Autologous and allogeneic mesenchymal stem cells in organ transplantation"],"prefix":"10.1097","volume":"19","author":[{"given":"Senthilkumar","family":"Alagesan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew D.","family":"Griffin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-12-20211004","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1001\/jama.2012.316","article-title":"Induction therapy with autologous mesenchymal stem cells in living-related kidney transplants: a randomized controlled trial.","volume":"307","author":"Tan","year":"2012","journal-title":"JAMA"},{"key":"R2-12-20211004","doi-asserted-by":"crossref","first-page":"107","DOI":"10.5966\/sctm.2012-0114","article-title":"Autologous bone marrow-derived mesenchymal stromal cells for the treatment of allograft rejection after renal transplantation: results of a phase I study.","volume":"2","author":"Reinders","year":"2013","journal-title":"Stem Cells Transl Med"},{"key":"R3-12-20211004","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1097\/TP.0b013e318298f9fa","article-title":"Mesenchymal stem cells in solid organ transplantation (MiSOT) fourth meeting: lessons learned from first clinical trials.","volume":"96","author":"Franquesa","year":"2013","journal-title":"Transplantation"},{"key":"R4-12-20211004","doi-asserted-by":"crossref","first-page":"412","DOI":"10.2215\/CJN.04950610","article-title":"Autologous mesenchymal stromal cells and kidney transplantation: a pilot study of safety and clinical feasibility.","volume":"6","author":"Perico","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"R5-12-20211004","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/TP.0b013e3182754c53","article-title":"Donor-derived mesenchymal stem cells combined with low-dose tacrolimus prevent acute rejection after renal transplantation: a clinical pilot study.","volume":"95","author":"Peng","year":"2013","journal-title":"Transplantation"},{"key":"R7-12-20211004","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1016\/S0140-6736(08)60690-X","article-title":"Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study.","volume":"371","author":"Le Blanc","year":"2008","journal-title":"Lancet"},{"key":"R8-12-20211004","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1136\/gut.2010.215152","article-title":"Autologous bone marrow-derived mesenchymal stromal cell treatment for refractory luminal Crohns disease: results of a phase I study.","volume":"59","author":"Duijvestein","year":"2010","journal-title":"Gut"},{"key":"R9-12-20211004","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1016\/j.jacc.2009.06.055","article-title":"A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarction.","volume":"54","author":"Hare","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"R10-12-20211004","doi-asserted-by":"crossref","first-page":"297","DOI":"10.3389\/fimmu.2012.00297","article-title":"Mesenchymal stem cells are short-lived and do not migrate beyond the lungs after intravenous infusion.","volume":"3","author":"Eggenhofer","year":"2012","journal-title":"Front Immunol"},{"key":"R11-12-20211004","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1002\/stem.1271","article-title":"Cell surface structures influence lung clearance rate of systemically infused mesenchymal stromal cells.","volume":"31","author":"Nystedt","year":"2013","journal-title":"Stem Cells"},{"key":"R12-12-20211004","first-page":"1565","article-title":"Are therapeutic human mesenchymal stromal cells compatible with human blood Stem C","volume":"30","author":"Moll","year":"2012","journal-title":"ells"},{"key":"R13-12-20211004","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1111\/j.1600-6143.2012.04115.x","article-title":"Localization of mesenchymal stromal cells dictates their immune or proinflammatory effects in kidney transplantation.","volume":"12","author":"Casiraghi","year":"2012","journal-title":"Am J Transplant"},{"key":"R14-12-20211004","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.stem.2012.08.013","article-title":"CCR2-dependent recruitment of macrophages by tumor-educated mesenchymal stromal cells promotes tumor development and is mimicked by TNF.","volume":"11","author":"Ren","year":"2012","journal-title":"Cell Stem Cell"},{"key":"R15-12-20211004","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1111\/j.1582-4934.2011.01509.x","article-title":"Immunogenicity of allogeneic mesenchymal stem cells.","volume":"16","author":"Schu","year":"2012","journal-title":"J Cell Mol Med"},{"key":"R16-12-20211004","first-page":"40","article-title":"Antidonor immune responses elicited by allogeneic mesenchymal stem cells: what have we learned so far Immunol Cell B","volume":"91","author":"Griffin","year":"2013","journal-title":"iol"},{"key":"R17-12-20211004","doi-asserted-by":"crossref","first-page":"202","DOI":"10.3389\/fimmu.2012.00202","article-title":"Detrimental effects of rat mesenchymal stromal cell pretreatment in a model of acute kidney rejection.","volume":"3","author":"Seifert","year":"2012","journal-title":"Front Immunol"},{"key":"R18-12-20211004","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1161\/CIRCULATIONAHA.110.955971","article-title":"Differentiation of allogeneic mesenchymal stem cells induces immunogenicity and limits their long-term benefits for myocardial repair.","volume":"122","author":"Huang","year":"2010","journal-title":"Circulation"},{"key":"R19-12-20211004","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/nri3209","article-title":"Multipotent mesenchymal stromal cells and the innate immune system.","volume":"12","author":"Le Blanc","year":"2012","journal-title":"Nat Rev Immunol"},{"key":"R20-12-20211004","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1038\/mt.2012.165","article-title":"Intravenous mesenchymal stem cells prevented rejection of allogeneic corneal transplants by aborting the early inflammatory response.","volume":"20","author":"Oh","year":"2012","journal-title":"Mol Ther"},{"key":"R21-12-20211004","doi-asserted-by":"crossref","first-page":"3933","DOI":"10.4049\/jimmunol.181.6.3933","article-title":"Pretransplant infusion of mesenchymal stem cells prolongs the survival of a semiallogeneic heart transplant through the generation of regulatory T cells.","volume":"181","author":"Casiraghi","year":"2008","journal-title":"J Immunol"},{"key":"R22-12-20211004","doi-asserted-by":"crossref","first-page":"595","DOI":"10.5966\/sctm.2012-0166","article-title":"Heart grafts tolerized through third-party multipotent adult progenitor cells can be retransplanted to secondary hosts with no immunosuppression.","volume":"2","author":"Eggenhofer","year":"2013","journal-title":"Stem Cells Transl Med"},{"key":"R23-12-20211004","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.trim.2011.06.002","article-title":"Features of synergism between mesenchymal stem cells and immunosuppressive drugs in a murine heart transplantation model.","volume":"25","author":"Eggenhofer","year":"2011","journal-title":"Transpl Immunol"},{"key":"R24-12-20211004","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1097\/TP.0b013e3181fed001","article-title":"Regulatory T-cell generation and kidney allograft tolerance induced by mesenchymal stem cells associated with indoleamine 2,3-dioxygenase expression.","volume":"90","author":"Ge","year":"2010","journal-title":"Transplantation"},{"key":"R25-12-20211004","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1111\/j.1600-6143.2009.02721.x","article-title":"Infusion of mesenchymal stem cells and rapamycin synergize to attenuate alloimmune responses and promote cardiac allograft tolerance.","volume":"9","author":"Ge","year":"2009","journal-title":"Am J Transplant"},{"key":"R26-12-20211004","doi-asserted-by":"crossref","first-page":"345","DOI":"10.3389\/fimmu.2012.00345","article-title":"Application of MultiStem allogeneic cells for immunomodulatory therapy: clinical progress and preclinical challenges in prophylaxis for graft versus host disease.","volume":"3","author":"Vaes","year":"2012","journal-title":"Front Immunol"},{"key":"R27-12-20211004","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1001\/jama.2012.25321","article-title":"Comparison of allogeneic versus autologous bone marrow-derived mesenchymal stem cells delivered by transendocardial injection in patients with ischemic cardiomyopathy: the poseidon randomized trial.","volume":"308","author":"Hare","year":"2012","journal-title":"JAMA"},{"key":"R28-12-20211004","first-page":"41","article-title":"Are cultured mesenchymal stromal cells an option for immunomodulation in transplantation Front I","volume":"4","author":"Plock","year":"2013","journal-title":"mmunol"},{"key":"R29-12-20211004","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1002\/stem.1270","article-title":"Mesenchymal stromal cells improve survival during sepsis in the absence of heme oxygenase-1: the importance of neutrophils.","volume":"31","author":"Hall","year":"2013","journal-title":"Stem Cells"},{"key":"R30-12-20211004","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1164\/rccm.201001-0010OC","article-title":"Mesenchymal stem cells reduce inflammation while enhancing bacterial clearance and improving survival in sepsis.","volume":"182","author":"Mei","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"key":"R31-12-20211004","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.stem.2012.10.001","article-title":"Preactivation of human MSCs with TNF- enhances tumor-suppressive activity.","volume":"11","author":"Lee Ryang","year":"2012","journal-title":"Cell Stem Cell"},{"key":"R32-12-20211004","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/j.stem.2012.11.016","article-title":"MSCs, macrophages, and cancer: a dangerous menage-a-trois.","volume":"11","author":"Mantovani","year":"2012","journal-title":"Cell Stem Cell"},{"key":"R33-12-20211004","doi-asserted-by":"crossref","first-page":"201","DOI":"10.3389\/fimmu.2013.00201","article-title":"Mesenchymal stem cells in tissue repair.","volume":"4","author":"Dimarino","year":"2013","journal-title":"Front Immunol"},{"key":"R34-12-20211004","doi-asserted-by":"crossref","first-page":"3125","DOI":"10.1089\/scd.2012.0096","article-title":"Mesenchymal stem cell therapy prevents interstitial fibrosis and tubular atrophy in a rat kidney allograft model.","volume":"21","author":"Franquesa","year":"2012","journal-title":"Stem Cells Dev"},{"key":"R35-12-20211004","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/icb.2012.62","article-title":"Cellular and molecular interactions of mesenchymal stem cells in innate immunity.","volume":"91","author":"Maria Spaggiari","year":"2013","journal-title":"Immunol Cell Biol"},{"key":"R36-12-20211004","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1038\/mt.2011.211","article-title":"Mesenchymal stemstromal cells (MSCs): role as guardians of inflammation.","volume":"20","author":"Prockop","year":"2012","journal-title":"Mol Ther"},{"key":"R37-12-20211004","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.stem.2010.05.012","article-title":"Pharmas developing interest in stem cells.","volume":"6","author":"McKernan","year":"2010","journal-title":"Cell Stem Cell"},{"key":"R38-12-20211004","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1038\/leu.2011.384","article-title":"Mesenchymal stromal cells for the treatment of graft-versus-host disease: understanding the in vivo biological effect through patient immune monitoring.","volume":"26","author":"Dander","year":"2012","journal-title":"Leukemia"},{"key":"R39-12-20211004","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.jcyt.2012.10.002","article-title":"The mesenchymal stromal cells dilemma: does a negative phase III trial of random donor mesenchymal stromal cells in steroid-resistant graft-versus-host disease represent a death knell or a bump in the road C","volume":"15","author":"Galipeau","year":"2013","journal-title":"ytotherapy"},{"key":"R40-12-20211004","doi-asserted-by":"crossref","first-page":"2935","DOI":"10.1111\/j.1582-4934.2012.01610.x","article-title":"Conditioned mesenchymal stem cells attenuate progression of chronic kidney disease through inhibition of epithelial-to-mesenchymal transition and immune modulation.","volume":"16","author":"Chang","year":"2012","journal-title":"J Cell Mol Med"},{"key":"R41-12-20211004","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1002\/stem.1047","article-title":"Adipose tissue-derived mesenchymal stem cells improve revascularization outcomes to restore renal function in swine atherosclerotic renal artery stenosis.","volume":"30","author":"Eirin","year":"2012","journal-title":"Stem Cells"},{"key":"R42-12-20211004","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1002\/jcb.22873","article-title":"Antifibrotic effect of chorionic plate-derived mesenchymal stem cells isolated from human placenta in a rat model of CCl(4)-injured liver: potential application to the treatment of hepatic diseases.","volume":"111","author":"Lee","year":"2010","journal-title":"J Cell Biochem"},{"key":"R43-12-20211004","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1164\/rccm.201207-1204PP","article-title":"Mesenchymal stem cells and idiopathic pulmonary fibrosis. Potential for clinical testing.","volume":"188","author":"Toonkel","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"R44-12-20211004","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1038\/mt.2012.183","article-title":"Gene-modified mesenchymal stem cells protect against radiation-induced lung injury.","volume":"21","author":"Xue","year":"2013","journal-title":"Mol Ther"},{"key":"R46-12-20211004","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1186\/1479-5876-11-171","article-title":"A prospective, nonrandomized, no placebo-controlled, phase Ib clinical trial to study the safety of the adipose derived stromal cells-stromal vascular fraction in idiopathic pulmonary fibrosis.","volume":"11","author":"Tzouvelekis","year":"2013","journal-title":"J Transl Med"},{"key":"R47-12-20211004","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1097\/MOT.0b013e32835c2939","article-title":"The role of mesenchymal stromal cells in chronic transplant rejection after solid organ transplantation.","volume":"18","author":"Reinders","year":"2013","journal-title":"Curr Opin Organ Transplant"}],"container-title":["Current Opinion in Organ Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00075200-201402000-00012","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,6]],"date-time":"2021-10-06T07:45:56Z","timestamp":1633506356000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00075200-201402000-00012"}},"subtitle":["what do we know about their safety and efficacy?"],"short-title":[],"issued":{"date-parts":[[2014,2]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.1097\/mot.0000000000000043","relation":{},"ISSN":["1087-2418"],"issn-type":[{"value":"1087-2418","type":"print"}],"subject":[],"published":{"date-parts":[[2014,2]]}}}